Registered Reporters Are Invited to Three Virtual MSVirtual2020 Press Conferences Featuring: The Latest Clinical Study Outcomes, Advances in Therapeutics, Diagnostics and Technologies, and Late Breakers and COVID-19 Impact on MS Research & Patient Ca

Newswise — The 8th Joint ACTRIMS-ECTRIMS meeting – the largest international conference focused on research in multiple sclerosis (MS), will be held in a virtual format from September 11-13, 2020, with a special encore session featuring Late-Breaking News and a COVID-19 Session on September 26.   At this virtual conference – MSVirtual2020 – world class scientists, neurologists, clinicians and researchers from around the world will be presenting the latest research, clinical trial outcomes and diagnostic advances in multiple sclerosis (MS). Registered reporters will have access to the full program and press events. 

MSVirtual2020 will have a Newsroom that will house material that media can use such as bios of leaders and key speakers, MS infographics, MSVirtual2020 press releases, videos of  ACTRIMS and ECTRIMS leaders, late breaker investigator summary videos (Available September 21  for media-only, under embargo), and other materials that may be of interest.  This Newsroom can be found at: https://www.newswise.com/home/actrims. 

This Newsroom site will host three live press events for media-only.  These events are designed to  provide reporters with opportunities to hear from the leaders and experts, and to directly ask them questions on the presentations being featured at the conference, clinial outcomes and breakthroughs, and some of the key advances being made in treatment, diagnostics and technologies as well as rehabilitation. There will also be three special press events focused on the late breakers and the Impact of COVID-19 on MS. The abstracts for this event will be available upon request to  press manager. The sessions will have a live Q&A  session where media will be able to ask questions directly to leaders.  

Link to Press Events: 

• The link will be: https://newswiselive.zoom.us/j/7459578068

 

PRESS EVENTS

Opening Press Conference with ACTRIMS and ECTRIMS Leaders with live Q&A (Media only)

• Date: Friday, September 11th @8:00 a.m. ET 
• Focus:  Key Highlights of Conference by ACTRIMS and ECTRIMS leaders 
• Featured Speakers:  
• Jeffrey Cohen, MD, President of ACTRIMS, Director of Mellen Center for Multiple Sclerosis Doctors, Cleveland Clinic
• Bernhard Hemmer, PhD,  President of ECTRIMS and Director of the Neurology Clinic Technical University of Munich (TUM), 
• Benjamin Segal, MD, Scientific Program Committee Co-Chair  of MSVirtual2020 and chair of the Department of Neurology and Director of the Neurological Research Institute at The Ohio State University College of Medicine, 
• Maria Pia Amato, MD, Scientific Program Committee Co-Chair  of MSVirtual2020, and Associate Professor of Neurology and head of MS Unit at the Department of Neurology, University of Florence
• Link to Press Event:  https://newswiselive.zoom.us/j/7459578068

 

• Virtual Coffee Break with ACTRIMS President and Q&A (Media Only)
• Date: Sunday, September 13th @ 7:30 a.m. ET
• Focus: A Q&A session where media will have the opportunity to ask the President questions regarding key conference presentations, clinical trial outcomes, advances in therapeutic research, technology and rehabilitation, and garner commentary from him. 
• Featured Leader: Jeffrey Cohen, MD, President of ACTRIMS, and Director of Mellen Center for Multiple Sclerosis Doctors, Cleveland Clinic
• Link to Press Event: https://newswiselive.zoom.us/j/7459578068

 

• Late-Breaker and COVID-19 Press Event – Live Q&A with Investigators (Media only)
• Date: Friday, September 25th @ 9:00 a.m.ET
• Focus: Live Q&A with Late Breaker and special COVID-19  Investigators
• Abstracts Available Under embargo as of September 21 upon request to press manager: [email protected]
• Featured Speakers:  Late Breaker and COVID-19 Investigators
• Link to Press Event: https://newswiselive.zoom.us/j/7459578068